Should we continue to indicate meglumine antimoniate as first-line treatment for cutaneous leishmaniasis in Tunisia (Q39256533)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Should we continue to indicate meglumine antimoniate as first-line treatment for cutaneous leishmaniasis in Tunisia |
scientific article |
Statements
1 reference
Should we continue to indicate meglumine antimoniate as first-line treatment for cutaneous leishmaniasis in Tunisia (English)
1 reference
Rym Benmously Mlika
1 reference
Myriam Ben Hamida
1 reference
Houda Hammami
1 reference
Salima Ben Jannet
1 reference
Talel Badri
1 reference
Sami Fenniche
1 reference
Inçaf Mokhtar
1 reference
1 November 2012
1 reference
1 reference
25
1 reference
6
1 reference
615-618
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference